Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy

Liver Transplantation

Volumn 20, Issue 9, 2014, Pages 1034-1044

  Chang, Yaojen ^a   Gallon, Lorenzo ^b   Jay, Colleen ^b   Shetty, Kirti ^c   Ho, Bing ^b   Levitsky, Josh ^b   Baker, Talia ^b   Ladner, Daniela ^b   Friedewald, John ^b   Abecassis, Michael ^b   Hazen, Gordon ^d   Skaro, Anton I ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CHRONIC LIVER FAILURE; CLINICAL DECISION MAKING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; END STAGE LIVER DISEASE; FEMALE; GRAFT FAILURE; HIDDEN MARKOV MODEL; HUMAN; KIDNEY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; RENAL REPLACEMENT THERAPY; SENSITIVITY ANALYSIS; SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION; SURGICAL PATIENT; SURVIVAL RATE; TIME; UNCERTAINTY; ADVERSE EFFECTS; COMPARATIVE STUDY; COMPLICATION; COMPUTER SIMULATION; DONOR; HOSPITAL ADMISSION; KIDNEY DISEASES; MIDDLE AGED; MORTALITY; PROCEDURES; RISK FACTOR; SUPPLY AND DISTRIBUTION; TIME TO TREATMENT; TREATMENT OUTCOME;

COMPARATIVE EFFECTIVENESS RESEARCH; COMPUTER SIMULATION; END STAGE LIVER DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MARKOV CHAINS; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84906666008     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23899     Document Type: Article

References (28)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2012.
2. Testino G, Ferro C,. Hepatorenal syndrome: a review. Hepatogastroenterology 2010; 57: 1279-1284.
3. Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006; 141: 735-741.
4. Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW,. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54: 462-470.
5. Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation 2008; 85: 935-942.
6. Moreno JM, Cuervas-Mons V, Rubio E, Pons F, Herreros de TA, Turriõn VS, Millán I,. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality. Transplant Proc 2003; 35: 1907-1908.
7. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N,. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6: 2651-2659.
8. Nair S, Verma S, Thuluvath PJ,. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-1185.
9. Moreno-Gonzalez E, Meneu-Diaz JC, García G, Jimenez Romero C, Loinaz Segurola C, Gomez Sanz R, et al. Simultaneous liver-kidney transplant for combined renal and hepatic end-stage disease. Transplant Proc 2003; 35: 1863-1865.
10. Lang M, Neumann U, Kahl A, Steinmüller T, Settmacher U, Neuhaus P,. Long-term outcome of 27 patients after combined liver-kidney transplantation. Transplant Proc 2001; 33: 1440-1441.
11. Papafragkakis H, Martin P, Akalin E,. Combined liver and kidney transplantation. Curr Opin Organ Transplant 2010; 15: 263-268.
12. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL,. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation 2006; 82: 1298-1303.
13. Thompson JA, Lake JR,. The impact of MELD allocation on simultaneous liver-kidney transplantation. Curr Gastroenterol Rep 2009; 11: 76-82.
14. Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 2007; 13: 838-843.
15. - 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. http://www.srtr.org/annual-reports. Accessed January 2012.
16. Sonnenberg FA, Beck JR,. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13: 322-338.
17. Siebert U, Alagoz, O, Bayoumi, AM, Jahn, B, Owens, DK, Cohen, DJ, Kuntz, KM; for, ISPOR-SMDM Modeling Good Research Practices Task Force,. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Value Health 2012; 15: 812-820.
18. Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH,. Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl 2010; 16: 440-446.
19. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
20. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
21. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
22. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
23. Hollingsworth JM, Hollenbeck BK, Englesbe MJ, DeMonner S, Krein SL,. Operative mortality after renal transplantation-does surgeon type matter? J Urol 2007; 177: 2255-2259.
24. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
25. Pham PT, Pham PC, Wilkinson AH,. Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Nat Clin Pract Nephrol 2007; 3: 507-514.
26. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD,. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008; 8: 2243-2251.
27. Schmitt TM, Kumer SC, Al-Osaimi A, Shah N, Argo CK, Berg C, et al. Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int 2009; 22: 876-883.
28. Organ Procurement and Transplantation Network. III. Policy proposals. http://optn.transplant.hrsa.gov/PublicComment/pubcommentPropSub-237.pdf. Accessed January 2014.